Scinai Immunotherapeutics Statistics
Total Valuation
SCNI has a market cap or net worth of $2.00 million. The enterprise value is $3.37 million.
Important Dates
The last earnings date was Friday, September 5, 2025, before market open.
| Earnings Date | Sep 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SCNI has 1.51 million shares outstanding. The number of shares has increased by 157.30% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 1.51M |
| Shares Change (YoY) | +157.30% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 10.70% |
| Owned by Institutions (%) | 10.16% |
| Float | 1.31M |
Valuation Ratios
The trailing PE ratio is 5.01.
| PE Ratio | 5.01 |
| Forward PE | n/a |
| PS Ratio | 1.51 |
| Forward PS | n/a |
| PB Ratio | 0.90 |
| P/TBV Ratio | 0.90 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 9.70 |
| EV / Sales | 2.93 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.71, with a Debt / Equity ratio of 0.30.
| Current Ratio | 0.71 |
| Quick Ratio | 0.53 |
| Debt / Equity | 0.30 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -6.67 |
Financial Efficiency
Return on equity (ROE) is 1,791.99% and return on invested capital (ROIC) is -44.45%.
| Return on Equity (ROE) | 1,791.99% |
| Return on Assets (ROA) | -39.55% |
| Return on Invested Capital (ROIC) | -44.45% |
| Return on Capital Employed (ROCE) | -86.89% |
| Revenue Per Employee | $37,000 |
| Profits Per Employee | $11,194 |
| Employee Count | 31 |
| Asset Turnover | 0.09 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -61.96% in the last 52 weeks. The beta is 1.84, so SCNI's price volatility has been higher than the market average.
| Beta (5Y) | 1.84 |
| 52-Week Price Change | -61.96% |
| 50-Day Moving Average | 1.64 |
| 200-Day Moving Average | 2.62 |
| Relative Strength Index (RSI) | 35.91 |
| Average Volume (20 Days) | 91,240 |
Short Selling Information
| Short Interest | 90,312 |
| Short Previous Month | 108,389 |
| Short % of Shares Out | 5.96% |
| Short % of Float | 6.90% |
| Short Ratio (days to cover) | 0.50 |
Income Statement
In the last 12 months, SCNI had revenue of $1.15 million and earned $347,000 in profits. Earnings per share was $0.26.
| Revenue | 1.15M |
| Gross Profit | -1.69M |
| Operating Income | -8.45M |
| Pretax Income | 5.14M |
| Net Income | 347,000 |
| EBITDA | -6.75M |
| EBIT | -8.45M |
| Earnings Per Share (EPS) | $0.26 |
Full Income StatementBalance Sheet
The company has $989,000 in cash and $2.36 million in debt, giving a net cash position of -$1.37 million or -$0.90 per share.
| Cash & Cash Equivalents | 989,000 |
| Total Debt | 2.36M |
| Net Cash | -1.37M |
| Net Cash Per Share | -$0.90 |
| Equity (Book Value) | 7.86M |
| Book Value Per Share | 1.47 |
| Working Capital | -614,000 |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$5.69 million and capital expenditures -$16,000, giving a free cash flow of -$5.71 million.
| Operating Cash Flow | -5.69M |
| Capital Expenditures | -16,000 |
| Free Cash Flow | -5.71M |
| FCF Per Share | -$3.77 |
Full Cash Flow StatementMargins
Gross margin is -146.99%, with operating and profit margins of -736.36% and 448.39%.
| Gross Margin | -146.99% |
| Operating Margin | -736.36% |
| Pretax Margin | 448.39% |
| Profit Margin | 448.39% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SCNI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -157.30% |
| Shareholder Yield | -157.30% |
| Earnings Yield | 17.36% |
| FCF Yield | -285.44% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
Stock Splits
The last stock split was on May 21, 2024. It was a reverse split with a ratio of 1:10.
| Last Split Date | May 21, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
SCNI has an Altman Z-Score of -16.28 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -16.28 |
| Piotroski F-Score | 3 |